deltatrials
Completed PHASE1 INTERVENTIONAL 2-arm NCT03451266

Effects of Vitamin C Administration on Extravascular Lung Water in Patients With Severe Features of Preeclampsia

Effects of Vitamin C Administration on Extravascular Lung Water in Patients With Severe Features of Preeclampsia: a Randomized, Placebo-controlled Trial

Sponsor: University Medical Centre Ljubljana

Updated 7 times since 2018 Last updated: Jun 27, 2019 Started: Apr 7, 2018 Primary completion: Jun 25, 2019 Completion: Jun 27, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Preeclampsia Postpartum and Preeclampsia Severe and is currently completed. University Medical Centre Ljubljana leads this study, which shows 7 recorded versions since 2018 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Mar 2018 – ~May 2018 · 2 months · monthly snapshotNot Yet Recruiting~May 2018 – ~Jun 2018 · 31 days · monthly snapshotRecruiting~Jun 2018 – ~Jul 2019 · 13 months · monthly snapshotRecruiting~Jul 2019 – ~Jan 2021 · 18 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

7 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE1

  4. Jul 2019 — Jan 2021 [monthly]

    Completed PHASE1

    Status: RecruitingCompleted

  5. Jun 2018 — Jul 2019 [monthly]

    Recruiting PHASE1

Show 2 earlier versions
  1. May 2018 — Jun 2018 [monthly]

    Recruiting PHASE1

    Status: Not Yet RecruitingRecruiting

  2. Mar 2018 — May 2018 [monthly]

    Not Yet Recruiting PHASE1

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • University Medical Centre Ljubljana
Data source: University Medical Centre Ljubljana

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations